Morphological alterations and NO-synthase expression in the heart after continuous light exposure of rats

Physiological Research

Volumn 56, Issue SUPPL. 2, 2007, Pages

  Paulis, L' ^a,b   Vazan R ^a,b   Simko F ^a   Pechanova O ^b,c   Styk, J ^b   Babal P ^a   Janega, P ^a,b  

^a Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Fibrosis collagen I III; Melatonin; Myocardium; Nitric oxide synthase

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; ENOS PROTEIN, RAT; INDUCIBLE NITRIC OXIDE SYNTHASE; NOS2 PROTEIN, RAT; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; BODY WEIGHT; ENZYMOLOGY; FIBROSIS; HEART MUSCLE CELL; LIGHT; MALE; METABOLISM; ORGAN SIZE; PATHOLOGY; RADIATION EXPOSURE; RAT; TIME; WISTAR RAT;

ANIMALS; BODY WEIGHT; COLLAGEN TYPE I; COLLAGEN TYPE III; FIBROSIS; LIGHT; MALE; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE TYPE II; ORGAN SIZE; RATS; RATS, WISTAR; TIME FACTORS;

EID: 38549085347     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BARRETT T, KENT S, VOUDOURIS N: Does melatonin modulate beta-endorphin, corticosterone, and pain threshold? Life Sci 66: 467-476, 2000.
2. BRIAUD SA, ZHANG BL, SANNAJUST F: Continuous light exposure and sympathectomy suppress circadian rhythm of blood pressure in rats. J Cardiovasc Pharmacol Ther 9: 97-105, 2004.
3. BRILLA CG, REAMS GP, MAISCH B WEBER KT: Renin-angiotensin system and myocardial fibrosis in hypertension: regulation of the myocardial collagen matrix. Eur Heart J 14 (Suppl J): 57-61, 1993.
4. BROWN GM, BAR-OR A, GROSSI D, KASHUR S, JOHANNSON E, YIE SM: Urinary 6-sulphatoxylmelatonin, an index of pineal function in the rat. J Pineal Res 10: 141-147, 1991.
5. BRUGGER P, MARKTL W, HEROLD M: Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet 345: 1408, 1995.
6. DELIBAS N, TUZMEN N, YONDEN Z, ALTUNTAS I: Effect of functional pinealectomy on hippocampal lipid peroxidation, antioxidant enzymes and N-methyl-D-aspartate receptor subunits 2A and 2B in young and old rats. Neuro Endocrinol Lett 23: 345-350, 2002.
7. DOLBER PC, SPACH MS: Conventional and confocal fluorescence microscopy of collagen fibers in the heart. J Histochem Cytochem 41: 465-469, 1993.
8. GARG UC, HASID A: Nitric oxide generating vasodilatators and 8-bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777, 1989.
9. GIROUARD H, DENAULT C, CHULAK C, DE CHAMPLAIN J: Treatment by n-acetylcysteine and melatonin increases cardiac baroreflex and improves antioxidant reserve. Am J Hypertens 17: 947-954, 2004.
10. JONAS M, GARFINKEL D, ZISAPEL N, LAUDON M, GROSSMAN E: Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Press 12: 19-24, 2003.
11. KOLPAKOV V, GORDON D, KULIK TJ: Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 9: 7-22, 1995.
12. MAXWELL AJ: Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide 6: 101-124, 2002.
13. MIZRAK B, PARLAKPINAR H, ACET A, TURKOZ Y: Effects of pinealectomy and exogenous melatonin on rat hearts. Acta Histochem 106: 29-36, 2004.
14. PATHAK M, SARKAR S, VELLAICHAMY E, SEN S: Role of myocytes in myocardial collagen production. Hypertension 37: 833-840, 2001.
15. PAULIS L', JANEGA P, PECHÁŇOVÁ O, ZICHA J, HOJNÁ S, VAŽAN R: Continuous light exposure protects rat heart against ischemia-reperfusion injury. Physiol Res 55: 2P, 2006.
16. REBUFFAT P, MAZZOCCHI G, GOTTARDO G, COI A, MENEGHELLI V, NUSSDORFER GG: An ultrastructural morphometric study of the effects of chronic melatonin administration on the zona fasciculata of rat adrenal cortex. J Submicrosc Cytol 19: 415-421, 1987.
17. ROSSI MA, RAMOS SG, PRADO CM: Chronic inhibition of nitric oxide synthase induces hypertension and cardiomyocyte mitochondrial and myocardial collagen remodelling in the absence of hypertrophy. J Hypertens 21: 993-1001, 2003.
18. SAHNA E, OLMEZ E, ACET A: Effects of physiological and pharmacological concentrations of melatonin on ischemia-reperfusion arrhythmias in rats: can the incidence of sudden cardiac death be reduced? J Pineal Res 32: 194-198, 2002a.
19. SAHNA E, ACET A, OZER MK, OLMEZ E: Myocardial ischemia-reperfusion in rats: reduction of infarct size by either supplemental physiological or pharmacological doses of melatonin. J Pineal Res 33: 234-238, 2002b.
20. SAHNA E, PARLAKPINAR H, TURKOZ Y, ACET A: Protective effects of melatonin on myocardial ischemia/reperfusion induced infarct size and oxidative changes. Physiol Res 54: 491-495, 2005.
21. TAN DX, MANCHESTER LC, REITER RJ, QI WB, KARBOWNIK M, CALVO JR: Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recept 9: 137-159, 2000.
22. 1 blockade stimulates extracellular collagen type I degradation and reverses myocardial fibrosis in spontaneously hypertensive rats. Hypertension 35: 1197-1202, 2000.
23. VAŽAN R, BÉDER I, STYK J: Melatonin and the heart (in Slovak). Cesk Fysiol 53: 29-33, 2004.
24. WEBER KT: Targeting pathological remodeling: concepts of cardioprotection and reparation. Circulation 102: 1342-1345, 2000.
25. WITTE K, GREBMER W, SCALBERT E, DELAGRANGE P, GUARDIOLA-LEMAITRE B, LEMMER B: Effects of melatoninergic agonists on light-suppressed circadian rhythms in rats. Physiol Behav 65: 219-224, 1998.
26. WOLDEN-HANSON T, MITTON DR, MCCANTS RL, YELLON SM, WILKINSON CW, MATSUMOTO AM, RASMUSSEN DD: Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 141: 487-497, 2000.
27. XU J, CUI G, ESMAILIAN F, PLUNKETT M, MARELLI D, ARDEHALI A, ODIM J, LAKS H, SEN L: Atrial extracellular matrix remodeling and the maintenance of atrial fibrillation. Circulation 109: 363-368, 2004.
28. YAMAMOTO K, MASUYAMA T, SAKATA Y, NISHIKAWA N, MANO T, YOSHIDA J, MIWA T, SUGAWARA M, YAMAGUCHI Y, OOKAWARA T, SUZUKI K, HORI M: Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. Cardiovasc Res 55: 76-82, 2002.
29. ZANOBONI A, ZANOBONI-MUCIACCIA W: Experimental hypertension in pinealectomized rats. Life Sci 6: 2327-2331, 1967.